ML
BHC icon

McAdam LLC’s Bausch Health BHC Stock Holding History

McAdam LLC’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,000
Closed -$27K – 107
2018
Q3 		$27K Hold
1,000
– – 0.01% 218
2018
Q2 		$23K Hold
1,000
– – 0.01% 218
2018
Q1 		$16K Buy
+1,000
New +$18.6K 0.01% 272

Other funds holding BHC

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

McAdam LLC's BHC Position: Q4 2018 in Review

McAdam LLC sold out of Bausch Health (BHC) in Q4 2018, closing a stake of 1,000 shares — an estimated $27K sold.

McAdam LLC first reported a position in BHC in Q1 2018 and held it in 3 quarters. The position peaked at $27K in Q3 2018. 334 funds tracked by Wall St. Rank hold BHC as of Q4 2018.

  • McAdam LLC reported no remaining Bausch Health position as of Q4 2018 after selling out during the quarter.
  • McAdam LLC sold 1,000 Bausch Health shares in Q4 2018, an estimated $27K.
  • McAdam LLC first reported a position in Bausch Health in Q1 2018 and held it in 3 quarters.
  • McAdam LLC's Bausch Health position peaked at $27K in Q3 2018.
  • 334 funds tracked by Wall St. Rank held Bausch Health as of Q4 2018.

Based on McAdam LLC's 13F filing for Q4 2018, filed 30 Jan 2019.